Aldosterone Testing During Pregnancy Should Be Deferred Until After Delivery
Aldosterone testing during pregnancy is not recommended because pregnancy is a physiologic hyperaldosteronism state that makes standard screening tests unreliable and uninterpretable. 1
Why Standard Testing Doesn't Work in Pregnancy
During pregnancy, the renin-angiotensin-aldosterone system undergoes dramatic physiologic changes that invalidate standard diagnostic criteria:
- Plasma renin activity (PRA) increases 4-7 fold by term due to additional renin sources from the uterus, ovaries, and placenta 1
- Aldosterone levels rise up to 10-fold above baseline, driven by estrogen-stimulated renin secretion 1
- The aldosterone-to-renin ratio (ARR) does not apply to pregnant women, making the standard screening test useless 1
- Progesterone acts as a competitive mineralocorticoid receptor antagonist, further confounding interpretation 1
What You Can Do Now (Limited Options)
While definitive diagnosis must wait until after delivery, you can look for suggestive features:
- Check for hypokalemia - this increases the probability of primary aldosteronism (PA), though potassium may be falsely normal due to progesterone's mineralocorticoid receptor effects 1
- Measure PRA - some authors suggest PRA below 4 ng/mL/h is suggestive of PA in pregnancy, though this is not well-validated 1
- High ARR with suppressed PRA plus consistent clinical features might be suggestive, but cannot confirm diagnosis 1
Confirmation tests (saline infusion, captopril challenge) are contraindicated during pregnancy due to risks of volume expansion and toxic effects 1
Management During Pregnancy
Focus on blood pressure control with pregnancy-safe medications:
- First-line: Methyldopa and/or beta-blockers 1
- Second-line: Amiloride (a potassium-sparing diuretic) with potassium supplementation if needed 1
- Consider in second trimester if BP uncontrolled: Spironolactone (FDA Category C) or eplerenone (FDA Category B), weighing maternal-fetal risks 1
Post-Delivery Plan
The definitive diagnosis can only be made after delivery 1. Plan to:
- Retest aldosterone and renin 4-6 weeks postpartum when the RAAS has normalized
- Perform confirmatory testing if screening is positive
- Consider imaging and adrenal vein sampling if unilateral disease is suspected
Clinical Context
Primary aldosteronism affects approximately 0.6% of pregnant women with hypertension (10% of hypertensive patients × 6-8% pregnancy hypertension rate) 1. While uncommon, it carries significant maternal and fetal risks when present 2. However, the physiologic changes of pregnancy make accurate diagnosis impossible until after delivery, so focus on safe blood pressure management now and plan systematic evaluation postpartum.